IRMD NASDAQ
IRadimed Corporation
1W: -4.9%
1M: -3.1%
3M: -10.9%
YTD: -11.9%
1Y: +7.8%
3Y: +124.5%
5Y: +151.2%
$83.95
-0.68 (-0.80%)
Pre-Market: $86.47 (+2.52, +3.00%)
Weekly Expected Move ±2.5%
$81
$84
$86
$88
$90
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: no debt. Altman Z 51.95.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (24h)
1
Hourly Sentiment (24h)
0.90
Bullish
1 bullish
0 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (47)
iRadimed Corporation (NASDAQ:IRMD) Stock Has Consensus Price Target of $120.00
NewEdge Advisors LLC Buys 8,063 Shares of iRadimed Corporation $IRMD
iRadimed Corporation (NASDAQ:IRMD) Receives $120.00 Average Price Target from Brokerages
Bank of New York Mellon Corp Makes New $7.25 Million Investment in iRadimed Corporation $IRMD
Algert Global LLC Sells 15,062 Shares of iRadimed Corporation $IRMD
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of “Moderate Buy” by Brokerages
IRadimed (IRMD) Q2 2026 Earnings Call Transcript
Bank of New York Mellon Corp Has $7.69 Million Position in iRadimed Corporation $IRMD
iRadimed declares $0.20 dividend
IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
Here are the major earnings before the open Friday
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline
iRadimed Corporation (NASDAQ:IRMD) Receives $120.00 Consensus Target Price from Analysts
IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It
Iradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?
Company News for May 4, 2026
Why Iradimed Stock Topped the Market Today
IRadimed outlines 2026 revenue of $91M-$96M as 3870 pump ASP lift trends near 20%
iRadimed declares $0.20 dividend
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
IRADIMED CORPORATION Reports First Quarter 2026 Financial Results
Earnings Scheduled For May 1, 2026
Here are the major earnings before the open Friday
iRadimed Q1 2026 Earnings Preview
Iradimed's CEO Dumped 7,500 Shares. Here's What That Means for Investors.
IRADIMED CORPORATION to Hold First Quarter 2026 Financial Results Conference Call on May 1, 2026
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
IRADIMED CORPORATION to Participate at the 25th Annual Needham Virtual Healthcare Conference
Analysts Set iRadimed Corporation (NASDAQ:IRMD) PT at $120.00
Roger Susi Sells 2,500 Shares of iRadimed (NASDAQ:IRMD) Stock
Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock
Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock
CEO Of iRadimed Sold $752K In Stock
3 Medical Instrument Stocks Tapping GenAI to Navigate Industry Woes
IRADIMED CORPORATION to Participate at the 38th Annual Roth Conference
5 Medical Instruments Stocks to Buy Amid Huge Short-Term Price Upside
Principal Financial Group Inc. Acquires New Holdings in iRadimed Corporation $IRMD
IRadimed Stock Up 80% in One Year as Fund Sells $29 Million Stake Amid Record Quarter
Why Iradimed Stock Soared Today
IRADIMED CORPORATION (IRMD) Q4 2025 Earnings Call Transcript
IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share
iRadimed Corporation (NASDAQ:IRMD) Given Average Rating of “Moderate Buy” by Analysts
Roger Susi Sells 5,000 Shares of iRadimed (NASDAQ:IRMD) Stock
Copeland Capital Management LLC Has $30.85 Million Holdings in iRadimed Corporation $IRMD
IRADIMED Announces Special Cash Dividend of $0.50 Per Share
iRadimed Corporation (NASDAQ:IRMD) Receives Average Recommendation of “Moderate Buy” from Analysts